“一带一路”倡议下中国与缅甸传统药物合作研发前景浅析

A brief analysis on the prospect of Chinese and Myanmar traditional medicines under the Belt and Road Initiative

缅甸是中国"一带一路"倡议向南开放、开展区域合作的重要门户。缅甸药用生物资源丰富,其传统医药已有两千年使用历史。中缅医药文化的共通性、药材资源和消费市场的互补性使两国传统医药贸易与合作研发潜力巨大,两国传统医药合作可作为"一带一路"实施的良好媒介和载体。本文简要概述了缅甸传统药物应用及研发情况,"一带一路"背景下两国开展传统医药合作的必要性及两国传统医药交流与合作近况,并对当前可开展合作研发的领域进行了分析。两国传统药物合作将能有效促进两国生物资源可持续利用及传统医药技术和资源的优势互补与共享。

Myanmar is an important gateway for China’s Belt and Road Initiative to open to the south and carry out regional cooperation.Medicinal bio-resources in Myanmar are plentiful,and traditional medicines in Myanmar have been used for two thousand years.Due to the intercommunity of medical culture and complementarity of medicinal material resources and consuming market,the commerce and cooperative research and development of traditional medicines between China and Myanmar are tremendously potential.The cooperation of traditional medicines between the two countries can be served as a good medium and carrier for performing the Belt and Road.In this review,the situation of application of traditional medicines in Myanmar are briefly summarized.The necessity and recent situation of cooperation and communication of traditional medicines between the two countries are also introduced,with the analysis of current fields that can be cooperated.The cooperation of traditional medicines between the two countries will effectively expedite the sustainable utilization of biological resources and the advantage complementarity and sharing of traditional medical technologies and resources.